Spider Rock Advisors, LLC Merck & Co., Inc. Put Options Transaction History

Spider Rock Advisors, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $1.38 Million - $1.61 Million	12,200 Added 62.24%	31,800 $4.2 Million
Q4 2023 Jan 30, 2024	BUY	$100.18 - $109.02 $1.92 Million - $2.09 Million	19,200 Added 4800.0%	19,600 $1.77 Million
Q3 2022 Nov 04, 2022	SELL	$84.53 - $94.96 $185,966 - $208,912	-2,200 Reduced 84.62%	400 $26,000
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $191,126 - $214,240	2,600 New	2,600 $158,000
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $182,806 - $202,202	-2,600 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $183,092 - $208,338	-2,600 Reduced 50.0%	2,600 $12,000
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $304,128 - $421,535	4,800 Added 1200.0%	5,200 $26,000
Q4 2019 Jan 17, 2020	BUY	$77.58 - $87.54 $31,032 - $35,016	400 New	400 $1,000

3,828

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.